| Similar Articles |
|---|
 |
The Motley Fool
August 10, 2010
Tim Hanson |
Don't Buy This Stock ... Yet Promising names that aren't quite buys.   |
The Motley Fool
August 12, 2010
Tim Hanson |
Don't Buy This Stock ... Yet Promising names that aren't quite buys. |
The Motley Fool
July 29, 2005
Shannon Zimmerman |
ExxonMobil Gushes Earnings The energy industry's 900-pound gorilla struts its stuff. Long-term investors hankering for additional energy exposure may want to take a hint and follow the company's lead. |
The Motley Fool
April 26, 2006
Stephen D. Simpson |
Calculating ConocoPhillips' Cheapness It's valued lower than many major oil companies -- but should it be? Unfortunately, first-quarter results don't lead to any immediate conclusions. Investors, take note. |
The Motley Fool
November 27, 2006
Will Frankenhoff |
Total: This Well Hasn't Run Dry Total has one of the best production growth rates among the major oil companies, is a leader in terms of reserve replacement ratios, carries an attractive valuation, and yields north of 3%. Investors, what's not to like? |
The Motley Fool
February 15, 2006
Stephen D. Simpson |
Total Tops the Charts Production growth and good cash flow make this an energy stock worth watching. |
The Motley Fool
December 12, 2006
Matthew Crews |
Smith & Nephew, What's the Deal? A merger with Biomet would be good in many ways. But what's the right price? Investors, take note. |
The Motley Fool
July 27, 2006
Stephen D. Simpson |
Smith & Nephew: Better Is Good Enough For British medical device company Smith & Nephew investors, better-than-expected is just fine. |
The Motley Fool
May 7, 2007
Toby Shute |
Total's Results Totally Expected The oil company's strength lies upstream, so investors needn't worry. |
The Motley Fool
February 7, 2011
David Lee Smith |
Despite Missing Expectations, Shell's Making Progress Shell's overall performance during the most recent quarter was essentially sound and generating solid improvements. |
The Motley Fool
February 9, 2006
Stephen D. Simpson |
Growth Not Enough for Smith & Nephew This orthopedic company has market-leading growth, but just not enough cash flow. Investors shouldn't get too excited about these shares. |
The Motley Fool
October 27, 2005
Stephen D. Simpson |
Will Smith & Nephew Keep Flexing? This smaller, British, orthopedic company has competitive products, but industry trends could hurt it. However, the entire orthopedic sector is getting pretty interesting from a value perspective. |
The Motley Fool
June 13, 2011
Isac Simon |
1 Well-Priced Energy Stock Unaffected by the Libyan Revolution Solid past performance coupled with ample reserves make Hess Corp. a winner. |
The Motley Fool
April 27, 2007
David Lee Smith |
Downstream Saves ExxonMobil's Day Refining and marketing take up the slack as exploration and production units slip at ExxonMobil. Investors, take note. |
The Motley Fool
November 1, 2011
David Lee Smith |
Exxon Resumes Its Big Daddy Role ExxonMobil's solid quarter has allowed it to recapture the top spot among public companies. |
The Motley Fool
August 8, 2011
Andrew Dominguez |
Big Oil Outlook: Major Oil Stocks With Bullish Options Sentiment What does the future look like for big oil? |
The Motley Fool
April 29, 2005
Stephen D. Simpson |
ExxonMobil: A Big Oil Slick? Declines in hydrocarbon production hurt first-quarter results and might indicate future troubles. |
The Motley Fool
November 6, 2006
Matthew Crews |
Smith & Nephew Is Hip to Growth The medical technology company is showing solid growth, but a possible acquisition is cause for concern. Investors, take note. |
The Motley Fool
January 31, 2005
Stephen D. Simpson |
Big Oil, Bigger Profits ExxonMobil reaps the benefits of rising energy prices yet again. Whether the future holds more expensive oil or cheaper oil, investors can probably count on ExxonMobil to be there making the most of it. |
The Motley Fool
April 21, 2006
Stephen D. Simpson |
Stryker Strikes a Chord A solid quarter and generally positive guidance refuels investor enthusiasm. |
The Motley Fool
October 4, 2005
Stephen D. Simpson |
Chesapeake's Movin' On Up With the purchase of Columbia Natural Resources, Chesapeake now stands as the third-largest gas producer in the U.S. The energy company has been trading at a valuation of just below $13 barrel of oil equivalent (boe) in proven reserves. |
The Motley Fool
August 31, 2011
Harsh Chauhan |
Medtronic Looks Set for Takeoff Medtronic shares jump after flat quarterly growth as it looks toward global expansion. |
The Motley Fool
April 29, 2011
David Lee Smith |
Big Oil Is Booming The likes of ExxonMobil, Royal Dutch Shell, and Occidental love these macro trends. |
The Motley Fool
January 29, 2007
Matthew Crews |
Only One Bone to Pick With Stryker With products for wherever you hurt, the med-tech company continues to deliver solid earnings. |
The Motley Fool
September 14, 2005
Stephen D. Simpson |
Orthopedic Sector Stumbles Already antsy about potential pricing, investors reacted badly to British orthopedic company Smith & Nephew's earnings guidance. |
The Motley Fool
May 1, 2009
David Lee Smith |
It's Still Hard to Beat Exxon With crude down by two-thirds, ExxonMobil's earnings slid by 58%. |
